Announcements Trials
Browse Landscape

Status

Completed 25Unknown 5Terminated 1Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 114Observational 5

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Blood Specimen Collection 85Surveys and Questionnaires 83Surgical Procedures, Operative 44Drug Therapy 32Radiotherapy 27Biopsy 26Amplified Fragment Length Polymorphism Analysis 24Neoadjuvant Therapy 23Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Data Collection 18Immunotherapy 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Magnetic Resonance Spectroscopy 16Liquid Biopsy 16pembrolizumab 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Observation 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 13Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Observational × Rituximab × Clear all
NCT05923879 2023-06-28

Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma

Ruijin Hospital

Unknown
30 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04127916 2020-03-18

Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)

Samsung Medical Center

Unknown
40 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT02732236 2018-04-18

Marginal Zone Lymphoma Cohort in Korea

Dong-A University Hospital

Unknown
500 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT02156726 2014-06-05

Q-lite

Czech CLL Study Group

Unknown
200 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00429065 2007-01-31

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Instituto Nacional de Cancerologia de Mexico

Unknown
30 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡